{"type":"video","version":"1.0","html":"<iframe src=\"https://www.loom.com/embed/9201a42a5d39481783eeff096ecbb907\" frameborder=\"0\" width=\"1920\" height=\"1440\" webkitallowfullscreen mozallowfullscreen allowfullscreen></iframe>","height":1440,"width":1920,"provider_name":"Loom","provider_url":"https://www.loom.com","thumbnail_height":1440,"thumbnail_width":1920,"thumbnail_url":"https://cdn.loom.com/sessions/thumbnails/9201a42a5d39481783eeff096ecbb907-a6b0a139229d5f7f.gif","duration":3020.24,"title":"IPC for PAD: A Proven Technology, Revitalized","description":"This Loom webinar explains how intermittent pneumatic compression therapy can support patients with peripheral arterial disease and related limb-threatening ischemia. Speakers from Aerospace Medical and medical advisor Dr John Evans discuss PAD’s global impact, key risk factors, diagnostic approaches like ABI and TBI, and why many cases are detected late, including critical limb-threatening ischemia with high amputation and mortality rates. Darren Bacuniac describes the Artera pneumatic compression device’s treatment protocol of 3-second compression cycles for 45 to 60 minutes one to three times daily, including clinical outcomes such as improved blood flow and walking distances. The webinar also covers Medicare reimbursement that resumed after around 2015, including E0675 and a 13-month rental with patient retention of the device and coverage for garments."}